19. Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity
In a recent publication in the well-respected journal Communications Biology, Iscaff Pharma’s innovative patient-derived scaffold technology explored 110 primary breast cancers to reveal [...]
